Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1357 results for "ibs"

IBS Yields to Rifaximin -- Repeatedly
MedPage Today

IBS Yields to Rifaximin -- Repeatedly

Meeting Coverage Published: Oct 22, 2014 PHILADELPHIA -- Treatment of diarrhea-predominant irritable bowel syndrome (IBS-D) with rifaximin was associated with significant symptomatic improvements, and treatment could be successfully repeated ... MedPage Today, 17 hours ago

309 images for ibs

IndiaTV News, 12 hours ago
Times of India, 1 day ago
Samaylive, 2 days ago
Expatriate Lifestyle, 2 days ago
Expatriate Lifestyle, 2 days ago
Daily Sun, 3 hours ago, 1 day ago
Irish Times, 3 days ago
Medical Xpress, 2 days ago
Mumbai Mirror, 5 days ago

Male IBS patients report more social stress

Male patients with irritable bowel syndrome (IBS) experience more interpersonal difficulties than their female counterparts, a study found.A disabling and intractable gastrointestinal disorder, IBS is twice as common among women than men."Our findings ...
 Prokerala2 days ago

Innovative Building Systems Adds Industry Veterans to Management Team

Largest Custom Modular Manufacturer in the U.S. Strengthens Team to Support Growth Innovative Building Systems (IBS) ( announced today that Kevin Flaherty and Doug Stimpson have joined the IBS team to further ...
 PRWeb1 day ago Innovative Building Systems Announces Intent to Acquire the Business...  PRWeb2 days ago

Synergy Pharma presents plecanatide IBS-C clinical trial results

News Editor At the American College of Gastroenterology Annual Scientific Meeting, Synergy Pharmaceuticals (SGYP +6.6%) presented data from a 423-patient Phase 2b dose-ranging study assessing the safety and efficacy of plecanatide in patients with ...
 Seeking Alpha1 day ago Synergy Pharmaceuticals Presents Positive Phase 2b Study Results for Plecanatide in IBS with Constipation  Drugs.com7 hours ago Synergy Pharmaceuticals : Phase 2b Study Results for Plecanatide in Patients to be Presented IBS-C at ACG Annual Scientific Meeting  4 Traders4 days ago Synergy Reports Results From Phase 2b Plecanatide Study - Quick Facts  RTTNews.com2 days ago

Nicer Foods To Make First Ever Protein Bars for People with IBS

Food start-up launching Kickstarter campaign to make bars free of corn, wheat, dairy, soy, and low in FODMAPs. FODMAPs are carbohydrates found in common foods, shown to trigger GI symptoms for many people with IBS. Love Your Guts. That's the slogan ...
 PRWeb1 day ago

Expert highlights research innovation and is optimistic about the future of IBS treatment

PUBLIC RELEASE DATE: 21-Oct-2014 (Vienna, October 21, 2014) Patients with irritable bowel syndrome (IBS) may at last be able to hope for a brighter future as innovative new treatments emerge and researchers clarify the role of current therapies.
 EurekAlert!2 days ago Ondansetron for the Treatment of IBS With Diarrhea  Medscape3 days ago
Securities Technology Monitor

Management Of Drug-Refractory IBS With Bovine Immunoglobulin Protein Isolate

Entera Health, Inc. Announces the Publication of a Scientific Article Summarizing Positive Responses to Oral Administration of Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI) in 10 Patients with Drug-Refractory IBS. Entera Health, Inc.
 PRWeb2 days ago

SYNTHETIC BIOLOGICS : Appoints Prominent Gastrointestinal GI Key Opinion Leaders to Irritable Bowel Syndrome IBS Clinical Advisory Board

By a News Reporter-Staff News Editor at Biotech Week -- Synthetic Biologics, Inc. ( NYSE MKT : SYN), a biotechnology company developing novel anti-infective biologics and drugs targeting specific pathogens that cause serious infections and ...
 4 Traders12 hours ago Synthetic Biologics Appoints Prominent Gastrointestinal (GI) Key Opinion Leaders to Irritable Bowel Syndrome (IBS) Clinical Advisory Board [Global Data Point]  TMC Net6 days ago Patent Issued for Rendering Improvement for 3D Display  4 Traders13 hours ago

Salix's TARGET 3 study examines the safety and efficacy of repeat treatment with Rifaximin for IBS with diarrhea

Salix Pharmaceuticals, Ltd. has announced that Dr. Anthony Lembo of Beth Israel Deaconess Medical Center will present the results of TARGET 3 in a late-breaking podium presentation at the American College of Gastroenterology meeting. Previously, ...
 Medical News Today31 minutes ago Salix Pharma (SLXP) to Present Data from Rifaximin 550 mg Phase 3 as IBS-D Treatment  Wall Street Business Network2 days ago Synergy Pharma (SGYP) Presents Statistically Significant Plecanatide Phase 2b Data in IBS-C  Town Hall2 days ago

World Bank, IBS to train procurement officers

As part of its efforts to promote fair and open competition in public and private organisations in Nigeria, the World Bank is providing technical support for Ibadan Business School in the training of procurement officers from across the country. ...
 Nigeria Punch1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less